Taken together, our study demonstrated that ESR1 promoter methylation was most likely induced by the SNAI2‐DNMT3B complex and resulted in enhanced EMT in ERα‐positive BC (Figure 6). This evidence concerns the gene DNMT3B and breast cancer.